Thalidomide back--under strict control.
Marwick
C
C
D004345:Drug Industry; D004335:Drug and Narcotic Control; D004989:Ethics; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D007917:Leprostatic Agents / Q000009:adverse effects / Q000627:therapeutic use; D013792:Thalidomide / Q000009:adverse effects / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration
D007166:Immunosuppressive Agents; D007917:Leprostatic Agents; D013792:Thalidomide